Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Use of cerebrospinal fluid levels of 14-3-3 in predicting neurodegeneration in confirmed BSE symptomatic cattle.

Robey WG, Jackson R, Walters RL, Brackett JM, Harrington CA, Killian WR.

Vet Rec. 1998 Jul 11;143(2):50-1. No abstract available.

PMID:
9699254
2.

Determination of anti-HBsAg IgM monoclonal antibodies in cell culture media by perfusion immunoassay.

Brackett JM, Cousineau KL, Wang H, Annapragada AV, Cabal OD, Gall GS, Peterson B, Robey WG.

J Immunol Methods. 1997 Jan 15;200(1-2):39-46.

PMID:
9005942
3.

Purity testing of recombinant proteins by capillary electrophoresis.

Kundu S, Fenters C, Lopez M, Calfin B, Winkler M, Robey WG.

J Capillary Electrophor. 1996 Nov-Dec;3(6):301-7.

PMID:
9384724
5.

Purification of commercial coomassie brilliant blue R-250 and characterization of the chromogenic fractions.

Kundu SK, Robey WG, Nabors P, Lopez MR, Buko A.

Anal Biochem. 1996 Mar 15;235(2):134-40.

PMID:
8833321
6.

Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein.

Miller MA, Mietzner TA, Cloyd MW, Robey WG, Montelaro RC.

AIDS Res Hum Retroviruses. 1993 Nov;9(11):1057-66.

PMID:
8312049
7.

Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120.

Arthur LO, Bess JW Jr, Waters DJ, Pyle SW, Kelliher JC, Nara PL, Krohn K, Robey WG, Langlois AJ, Gallo RC, et al.

J Virol. 1989 Dec;63(12):5046-53.

8.

Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120).

Pyle SW, Morein B, Bess JW Jr, Akerblom L, Nara PL, Nigida SM Jr, Lerche NW, Robey WG, Fischinger PJ, Arthur LO.

Vaccine. 1989 Oct;7(5):465-73.

PMID:
2554608
9.

HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.

Mann DL, Read-Connole E, Arthur LO, Robey WG, Wernet P, Schneider EM, Blattner WA, Popovic M.

J Immunol. 1988 Aug 15;141(4):1131-6.

PMID:
2840463
10.

Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies.

Nara PL, Robey WG, Pyle SW, Hatch WC, Dunlop NM, Bess JW Jr, Kelliher JC, Arthur LO, Fischinger PJ.

J Virol. 1988 Aug;62(8):2622-8.

11.
12.

Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus.

Montelaro RC, Robey WG, West MD, Issel CJ, Fischinger PJ.

J Gen Virol. 1988 Jul;69 ( Pt 7):1711-7.

PMID:
2839603
13.

Restricted heterogeneity of antibody to gp120 and p24 in AIDS.

Grimaldi LM, Roos RP, Devare SG, Robey WG, Casey JM, Gurney ME, Apatoff BR, Lazzarin D.

J Immunol. 1988 Jul 1;141(1):114-7.

PMID:
2837506
15.

Partial purification of native HIV transmembrane protein gp41: generation of polyclonal and monoclonal antibodies.

Zweig M, Showalter SD, Bladen SV, Gilden RV, Arthur LO, Robey WG, Nara PL, Fischinger PJ.

AIDS Res Hum Retroviruses. 1988 Feb;4(1):51-62. Erratum in: AIDS Res Hum Retroviruses 1988 Jun;4(3):237.

PMID:
3259140
16.

Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine.

Arthur LO, Pyle SW, Nara PL, Bess JW Jr, Gonda MA, Kelliher JC, Gilden RV, Robey WG, Bolognesi DP, Gallo RC, et al.

Proc Natl Acad Sci U S A. 1987 Dec;84(23):8583-7.

17.

Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.

Nara PL, Robey WG, Arthur LO, Asher DM, Wolff AV, Gibbs CJ Jr, Gajdusek DC, Fischinger PJ.

J Virol. 1987 Oct;61(10):3173-80.

18.
19.

HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemia.

Robert-Guroff M, Giardina PJ, Robey WG, Jennings AM, Naugle CJ, Akbar AN, Grady RW, Hilgartner MW.

J Immunol. 1987 Jun 1;138(11):3731-6.

PMID:
3495568
21.

Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.

Cease KB, Margalit H, Cornette JL, Putney SD, Robey WG, Ouyang C, Streicher HZ, Fischinger PJ, Gallo RC, DeLisi C, et al.

Proc Natl Acad Sci U S A. 1987 Jun;84(12):4249-53. Erratum in: Proc Natl Acad Sci U S A 1988 Nov;85(21):8226.

22.

HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis.

Mann DL, Lasane F, Popovic M, Arthur LO, Robey WG, Blattner WA, Newman MJ.

J Immunol. 1987 Apr 15;138(8):2640-4.

PMID:
3031162
23.

A specific assay measuring binding of 125I-Gp 120 from HIV to T4+/CD4+ cells.

Lundin K, Nygren A, Arthur LO, Robey WG, Morein B, Ramstedt U, Gidlund M, Wigzell H.

J Immunol Methods. 1987 Feb 26;97(1):93-100.

PMID:
3029227
24.

Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III.

Henderson LE, Sowder R, Copeland TD, Oroszlan S, Arthur LO, Robey WG, Fischinger PJ.

J Virol. 1987 Feb;61(2):629-32.

25.
26.

Stages in the progression of HIV infection in chimpanzees.

Saxinger C, Alter HJ, Eichberg JW, Fauci AS, Robey WG, Gallo RC.

AIDS Res Hum Retroviruses. 1987;3(4):375-85.

PMID:
3482160
27.

Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody.

Nara PL, Hatch WC, Dunlop NM, Robey WG, Arthur LO, Gonda MA, Fischinger PJ.

AIDS Res Hum Retroviruses. 1987 Fall;3(3):283-302.

PMID:
3481271
28.

Rapid assessment of relationships among HIV isolates by oligopeptide analyses of external envelope glycoproteins.

Robey WG, Nara PL, Poore CM, Popovic M, McLane MF, Barin F, Essex M, Fischinger PJ.

AIDS Res Hum Retroviruses. 1987;3(4):401-8.

PMID:
2833916
29.

Purification of 120,000 dalton envelope glycoprotein from culture fluids of human immunodeficiency virus (HIV)-infected H9 cells.

Pyle SW, Bess JW Jr, Robey WG, Fischinger PJ, Gilden RV, Arthur LO.

AIDS Res Hum Retroviruses. 1987;3(4):387-400.

PMID:
2833915
30.

Restricted neutralization of divergent HTLV-III/LAV isolates by antibodies to the major envelope glycoprotein.

Matthews TJ, Langlois AJ, Robey WG, Chang NT, Gallo RC, Fischinger PJ, Bolognesi DP.

Haematol Blood Transfus. 1987;31:414-22.

PMID:
2832276
31.

Simultaneous isolation of simian foamy virus and HTLV-III/LAV from chimpanzee lymphocytes following HTLV-III or LAV inoculation.

Nara PL, Robey WG, Arthur LO, Gonda MA, Asher DM, Yanagihara R, Gibbs CJ Jr, Gajdusek DC, Fischinger PJ.

Arch Virol. 1987;92(1-2):183-6.

PMID:
2432853
32.

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope.

Putney SD, Matthews TJ, Robey WG, Lynn DL, Robert-Guroff M, Mueller WT, Langlois AJ, Ghrayeb J, Petteway SR Jr, Weinhold KJ, et al.

Science. 1986 Dec 12;234(4782):1392-5.

PMID:
2431482
33.

Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity.

Pert CB, Hill JM, Ruff MR, Berman RM, Robey WG, Arthur LO, Ruscetti FW, Farrar WL.

Proc Natl Acad Sci U S A. 1986 Dec;83(23):9254-8.

34.

Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein.

Matthews TJ, Langlois AJ, Robey WG, Chang NT, Gallo RC, Fischinger PJ, Bolognesi DP.

Proc Natl Acad Sci U S A. 1986 Dec;83(24):9709-13.

35.

In vitro generation of an HTLV-III variant by neutralizing antibody.

Robert-Guroff M, Reitz MS Jr, Robey WG, Gallo RC.

J Immunol. 1986 Nov 15;137(10):3306-9.

PMID:
3639908
36.

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.

Robey WG, Arthur LO, Matthews TJ, Langlois A, Copeland TD, Lerche NW, Oroszlan S, Bolognesi DP, Gilden RV, Fischinger PJ.

Proc Natl Acad Sci U S A. 1986 Sep;83(18):7023-7.

37.

Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera.

Kan NC, Franchini G, Wong-Staal F, DuBois GC, Robey WG, Lautenberger JA, Papas TS.

Science. 1986 Mar 28;231(4745):1553-5.

PMID:
3006245
38.

HTLV-III antibody in a breeding chimpanzee not experimentally exposed to the virus.

Gilden RV, Arthur LO, Robey WG, Kelliher JC, Graham CE, Fischinger PJ.

Lancet. 1986 Mar 22;1(8482):678-9. No abstract available.

PMID:
2869366
39.

Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).

Fischinger PJ, Robey WG, Koprowski H, Gallo RC, Bolognesi DP.

Cancer Res. 1985 Sep;45(9 Suppl):4694s-4699s. Review.

40.

Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients.

Robey WG, Safai B, Oroszlan S, Arthur LO, Gonda MA, Gallo RC, Fischinger PJ.

Science. 1985 May 3;228(4699):593-5.

PMID:
2984774
41.

Generation of thymotropic envelope gene recombinant virus and induction of lymphoma by ecotropic Moloney murine leukemia virus.

Fischinger PJ, Dunlop NM, Robey WG, Schäfer W.

Virology. 1985 Apr 15;142(1):197-205.

PMID:
4060571
42.

Thymotropic envelope gene recombinants of Moloney leukemia virus have highly conserved envelope structures.

Robey WG, Dekaban GA, Ball JK, Poore CM, Fischinger PJ.

Virology. 1985 Apr 15;142(1):183-96.

PMID:
2997979
43.

Isolation from cats of an endogenous type C virus with a novel envelope glycoprotein.

Haapala DK, Robey WG, Oroszlan SD, Tsai WP.

J Virol. 1985 Mar;53(3):827-33.

44.

Pathogenesis and virus content of lymphomas induced by pure ecotropic Graffi murine leukemia virus.

Fischinger PJ, Dunlop NM, Robey WG.

Int J Radiat Oncol Biol Phys. 1985 Feb;11(2):241-51.

PMID:
2982768
45.

Molecular biological characterization of a highly leukaemogenic virus isolated from the mouse. IV. Viral proteins.

Dekaban GA, Ball JK, Robey WG, Arthur LO, McCarter JA.

J Gen Virol. 1984 Oct;65 ( Pt 10):1791-802.

PMID:
6208318
46.

The role of viral and cellular recombinational events in murine leukemia.

Fischinger PJ, Dunlop NM, Dekaban GA, Robey WG.

Transplant Proc. 1984 Apr;16(2):428-34. No abstract available.

PMID:
6326352
47.

Generation of recombinant murine leukemia viruses de novo: an alternative model for leukemogenesis.

Fischinger PJ, Dunlop NM, Poore CM, Robey WG.

Haematol Blood Transfus. 1983;28:261-9.

PMID:
6305796
48.

Presence of a novel recombinant murine leukemia virus-like glycoprotein on the surface of virus-negative C57BL lymphoma cells.

Fischinger PJ, Thiel HJ, Lieberman M, Kaplan HS, Dunlop NM, Robey WG.

Cancer Res. 1982 Nov;42(11):4650-7. No abstract available.

49.

Persistence of one species of oncovirus in mixed infection after antiserum treatment or transspecies rescue.

Fischinger PJ, Robey WG, Blair DG, Blevins CS, Dunlop NM.

J Gen Virol. 1982 Oct;62 (Pt 2):393-8.

PMID:
7142977
50.

Supplemental Content

Loading ...
Support Center